King's College London Promoting Early Presentation Group, St Thomas' Hospital, London SE1 7EH, UK.
BMC Med Res Methodol. 2010 Dec 22;10:110. doi: 10.1186/1471-2288-10-110.
The purpose of this study was to explore women's views of the design of a large pragmatic cost-effectiveness randomised controlled trial of the policy of offering a health professional-delivered intervention to promote early presentation with breast symptoms in older women and thereby improve survival, with a view to informing protocol development. The trial will recruit over 100,000 healthy women aged 67+, and outcome data will be collected on those who develop breast cancer. The scale of the trial and the need for long-term follow-up presented a number of design challenges in relation to obtaining consent, ascertaining and contacting participants who developed breast cancer, and collecting outcome data.
Qualitative study involving 69 women participating in 7 focus groups and 17 in-depth interviews. 15 women had a previous diagnosis of breast cancer and 54 did not.
The women held strong views and had a good understanding of the rationale of the design of clinical trials. The women recognised that in a very large trial with long-term follow-up it was necessary to incorporate design features to make the trial feasible and efficient. Most strikingly, they supported the idea of opt-out consent and identifying women with breast cancer using routine datasets.
This model of user involvement engaged women well with the design challenges of the trial and led to improvements to the protocol. The study strengthens the case for user involvement, in particular through focus groups and in-depth interviews, in the design of trials.
本研究旨在探讨女性对一项大型实用成本效益随机对照试验设计的看法,该试验旨在针对老年女性乳房症状提出一项卫生专业人员提供的干预措施的政策,以提高早期就诊率,从而改善生存状况,为制定方案提供依据。该试验将招募超过 100,000 名 67 岁以上的健康女性,对出现乳腺癌的女性将收集其结局数据。试验规模庞大,需要长期随访,这给同意书的获取、确定和联系出现乳腺癌的参与者以及收集结局数据带来了一些设计挑战。
采用定性研究方法,纳入 69 名参加 7 次焦点小组和 17 次深入访谈的女性。15 名女性曾被诊断患有乳腺癌,54 名女性未被诊断。
女性对临床试验设计的原理持有强烈的观点和良好的理解。女性认识到,在一项具有长期随访的大型试验中,必须采用设计特征使试验可行且高效。最引人注目的是,她们支持默认同意的想法,并使用常规数据集来确定患有乳腺癌的女性。
这种用户参与模式使女性很好地参与了试验的设计挑战,并对方案进行了改进。该研究支持用户参与,特别是通过焦点小组和深入访谈,参与试验设计。